Advertisement
Screener

Lineage Cell Therapeutics, Inc. (LCTX) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

Lineage Cell Therapeutics, Inc. Stock-Based Compensation

Lineage Cell Therapeutics, Inc. (LCTX) reported Stock-Based Compensation of $2.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-06

  • Lineage Cell Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $1.60M, a 29.32% increase year-over-year.
  • Lineage Cell Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $1.17M, a 3.70% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $1.10M, a 16.50% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $1.20M, a 9.85% decline year-over-year.
  • Lineage Cell Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $4.75M, a 6.40% decline from fiscal 2024.
  • Lineage Cell Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $5.08M, a 9.42% increase from fiscal 2023.
  • Lineage Cell Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $4.64M, a 8.23% increase from fiscal 2022.
  • Lineage Cell Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $4.29M, a 21.82% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2026-06-30$1.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$2.77M
10-Q · filed 2026-08-06
$3.87M
derived: sum of 3 quarters · filed 2026-08-06
$5.07M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$1.17M
10-Q · filed 2026-05-12
$2.27M
derived: sum of 2 quarters · filed 2026-05-12
$3.47M
derived: sum of 3 quarters · filed 2026-05-12
$4.71M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$2.30M
derived: sum of 2 quarters · filed 2026-03-05
$3.54M
derived: sum of 3 quarters · filed 2026-08-06
$4.75M
10-K · filed 2026-03-05
2025-09-30$1.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$2.44M
derived: sum of 2 quarters · filed 2026-08-06
$3.65M
10-Q · filed 2025-11-06
$4.97M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$1.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$2.46M
10-Q · filed 2026-08-06
$3.77M
derived: sum of 3 quarters · filed 2026-08-06
$5.10M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$1.22M
10-Q · filed 2026-05-12
$2.53M
derived: sum of 2 quarters · filed 2026-05-12
$3.86M
derived: sum of 3 quarters · filed 2026-05-12
$5.13M
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$1.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05
$2.65M
derived: sum of 2 quarters · filed 2026-03-05
$3.91M
derived: sum of 3 quarters · filed 2026-03-05
$5.08M
10-K · filed 2026-03-05
2024-09-30$1.33M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$2.60M
derived: sum of 2 quarters · filed 2025-11-06
$3.76M
10-Q · filed 2025-11-06
$4.82M
derived: sum of 4 quarters · filed 2025-11-06
2024-06-30$1.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12
$2.43M
10-Q · filed 2025-08-12
$3.49M
derived: sum of 3 quarters · filed 2025-08-12
$4.76M
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$1.16M
10-Q · filed 2025-05-13
$2.22M
derived: sum of 2 quarters · filed 2025-05-13
$3.49M
derived: sum of 3 quarters · filed 2025-05-13
$4.77M
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$1.06M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-10
$2.33M
derived: sum of 2 quarters · filed 2025-03-10
$3.61M
derived: sum of 3 quarters · filed 2025-03-10
$4.64M
10-K · filed 2025-03-10
2023-09-30$1.27M
10-Q · filed 2023-11-09
$2.55M
derived: sum of 2 quarters · filed 2023-11-09
$3.58M
10-Q · filed 2024-11-14
$4.54M
derived: sum of 4 quarters · filed 2024-05-09
2023-06-30$1.28M
10-Q · filed 2023-08-10
$2.31M
10-Q · filed 2024-08-08
$3.27M
derived: sum of 3 quarters · filed 2024-05-09
$4.26M
derived: sum of 4 quarters · filed 2024-05-09
2023-03-31$1.03M
10-Q · filed 2024-05-09
$1.99M
derived: sum of 2 quarters · filed 2024-05-09
$2.98M
derived: sum of 3 quarters · filed 2024-05-09
$4.21M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$959.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07
$1.95M
derived: sum of 2 quarters · filed 2024-03-07
$3.18M
derived: sum of 3 quarters · filed 2024-03-07
$4.29M
10-K · filed 2024-03-07
2022-09-30$987.00K
10-Q · filed 2023-11-09
$2.22M
derived: sum of 2 quarters · filed 2023-11-09
$3.33M
10-Q · filed 2023-11-09
$4.25M
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$1.24M
10-Q · filed 2023-08-10
$2.34M
10-Q · filed 2023-08-10
$3.26M
derived: sum of 3 quarters · filed 2023-08-10
$4.40M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31$1.11M
10-Q · filed 2023-05-11
$2.02M
derived: sum of 2 quarters · filed 2023-05-11
$3.17M
derived: sum of 3 quarters · filed 2023-05-11
$4.09M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31$918.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
$2.06M
derived: sum of 2 quarters · filed 2023-03-09
$2.98M
derived: sum of 3 quarters · filed 2023-03-09
$3.52M
10-K · filed 2023-03-09
2021-09-30$1.14M
10-Q · filed 2022-11-10
$2.06M
derived: sum of 2 quarters · filed 2022-11-10
$2.60M
10-Q · filed 2022-11-10
$3.10M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$919.00K
10-Q · filed 2022-08-11
$1.46M
10-Q · filed 2022-08-11
$1.95M
derived: sum of 3 quarters · filed 2022-08-11
$2.45M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$539.00K
10-Q · filed 2022-05-12
$1.03M
derived: sum of 2 quarters · filed 2022-05-12
$1.53M
derived: sum of 3 quarters · filed 2022-05-12
$2.14M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$494.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
$995.00K
derived: sum of 2 quarters · filed 2022-03-10
$1.60M
derived: sum of 3 quarters · filed 2022-03-10
$2.23M
10-K · filed 2022-03-10
2020-09-30$501.00K
10-Q · filed 2021-11-10
$1.11M
derived: sum of 2 quarters · filed 2021-11-10
$1.73M
10-Q · filed 2021-11-10
$2.35M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$606.00K
10-Q · filed 2021-08-12
$1.23M
10-Q · filed 2021-08-12
$1.85M
derived: sum of 3 quarters · filed 2021-08-12
$2.61M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$626.00K
10-Q · filed 2021-05-13
$1.25M
derived: sum of 2 quarters · filed 2021-05-13
$2.00M
derived: sum of 3 quarters · filed 2021-05-13
$2.77M
derived: sum of 4 quarters · filed 2021-05-13
2019-12-31$619.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11
$1.38M
derived: sum of 2 quarters · filed 2021-03-11
$2.14M
derived: sum of 3 quarters · filed 2021-03-11
$3.58M
10-K · filed 2021-03-11
2019-09-30$759.00K
10-Q · filed 2020-11-04
$1.52M
derived: sum of 2 quarters · filed 2020-11-04
$2.96M
10-Q · filed 2020-11-04
$4.97M
derived: sum of 4 quarters · filed 2020-11-04
2019-06-30$762.00K
10-Q · filed 2020-08-06
$2.20M
10-Q · filed 2020-08-06
$4.21M
derived: sum of 3 quarters · filed 2020-08-06
$5.52M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31$1.44M
10-Q · filed 2020-05-07
$3.44M
derived: sum of 2 quarters · filed 2020-05-07
$4.75M
derived: sum of 3 quarters · filed 2020-05-07
$5.86M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12
$3.31M
derived: sum of 2 quarters · filed 2020-03-12
$4.42M
derived: sum of 3 quarters · filed 2020-03-12
$5.40M
10-K · filed 2020-03-12
2018-09-30$1.31M
10-Q · filed 2019-11-12
$2.41M
derived: sum of 2 quarters · filed 2019-11-12
$3.40M
10-Q · filed 2019-11-12
$4.43M
derived: sum of 4 quarters · filed 2019-11-12
2018-06-30$1.10M
10-Q · filed 2019-08-08
$2.09M
10-Q · filed 2019-08-08
$3.12M
derived: sum of 3 quarters · filed 2019-08-08
$4.09M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31$984.00K
10-Q · filed 2019-05-09
$2.01M
derived: sum of 2 quarters · filed 2019-05-09
$2.99M
derived: sum of 3 quarters · filed 2019-05-09
$3.89M
derived: sum of 4 quarters · filed 2019-05-09
2017-12-31$1.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14
$2.00M
derived: sum of 2 quarters · filed 2019-03-14
$2.91M
derived: sum of 3 quarters · filed 2019-03-14
$3.93M
10-K · filed 2019-03-14
2017-09-30$973.00K
10-Q · filed 2018-11-08
$1.88M
derived: sum of 2 quarters · filed 2018-11-08
$2.90M
10-Q · filed 2018-11-08
$4.55M
derived: sum of 4 quarters · filed 2018-11-08
2017-06-30$905.00K
10-Q · filed 2018-08-02
$1.93M
10-Q · filed 2018-08-02
$3.58M
derived: sum of 3 quarters · filed 2018-08-02
$4.29M
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31$1.03M
10-Q · filed 2018-05-10
$2.67M
derived: sum of 2 quarters · filed 2018-05-10
$3.38M
derived: sum of 3 quarters · filed 2018-05-10
$5.60M
derived: sum of 4 quarters · filed 2018-05-10
2016-12-31$1.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$2.36M
derived: sum of 2 quarters · filed 2018-03-15
$4.58M
derived: sum of 3 quarters · filed 2018-03-15
$7.95M
10-K · filed 2018-03-15
2016-09-30$710.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$2.93M
derived: sum of 2 quarters · filed 2017-11-09
$6.30M
10-Q · filed 2017-11-09
$10.16M
derived: sum of 4 quarters · filed 2018-03-15
2016-06-30$2.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09
$5.59M
10-Q · filed 2017-08-09
$9.45M
derived: sum of 3 quarters · filed 2018-03-15
$12.94M
derived: sum of 4 quarters · filed 2018-03-15
2016-03-31$3.37M
10-Q · filed 2017-05-10
$7.23M
derived: sum of 2 quarters · filed 2018-03-15
$10.72M
derived: sum of 3 quarters · filed 2018-03-15
$12.51M
derived: sum of 4 quarters · filed 2018-03-15
2015-12-31$3.86M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15
$7.35M
derived: sum of 2 quarters · filed 2018-03-15
$9.14M
derived: sum of 3 quarters · filed 2018-03-15
$11.05M
10-K · filed 2018-03-15
2015-09-30$3.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$5.28M
derived: sum of 2 quarters · filed 2015-11-09
$7.19M
10-Q · filed 2015-11-09
$8.32M
derived: sum of 4 quarters · filed 2017-03-16
2015-06-30$1.79M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$3.70M
10-Q · filed 2015-08-10
$4.83M
derived: sum of 3 quarters · filed 2017-03-16
$5.94M
derived: sum of 4 quarters · filed 2017-03-16
2015-03-31$1.91M
10-Q · filed 2016-05-10
$1.91M
10-Q · filed 2015-05-08
$3.05M
derived: sum of 2 quarters · filed 2017-03-16
$4.16M
derived: sum of 3 quarters · filed 2017-03-16
$5.57M
derived: sum of 4 quarters · filed 2017-03-16
2014-12-31$1.13M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16
$2.24M
derived: sum of 2 quarters · filed 2017-03-16
$3.65M
derived: sum of 3 quarters · filed 2017-03-16
$4.46M
10-K · filed 2017-03-16
$4.46M
10-K · filed 2015-03-11
2014-09-30$1.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09
$2.52M
derived: sum of 2 quarters · filed 2015-11-09
$3.32M
10-Q · filed 2015-11-09
$3.32M
10-Q · filed 2014-11-07
$4.16M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$1.41M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10
$2.21M
10-Q · filed 2015-08-10
$2.21M
10-Q · filed 2014-08-11
$3.05M
derived: sum of 3 quarters · filed 2016-03-15
$4.08M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31$801.55K
10-Q · filed 2015-05-08
$1.64M
derived: sum of 2 quarters · filed 2016-03-15
$2.67M
derived: sum of 3 quarters · filed 2016-03-15
$3.33M
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31$842.65K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$1.87M
derived: sum of 2 quarters · filed 2016-03-15
$2.53M
derived: sum of 3 quarters · filed 2016-03-15
$3.22M
10-K · filed 2016-03-15
$3.22M
10-K · filed 2014-03-17
2013-09-30$1.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07
$1.68M
derived: sum of 2 quarters · filed 2014-11-07
$2.38M
10-Q · filed 2014-11-07
$2.78M
derived: sum of 4 quarters · filed 2015-03-11
2013-06-30$659.85K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11
$1.35M
10-Q · filed 2014-08-11
$1.75M
derived: sum of 3 quarters · filed 2015-03-11
$2.27M
derived: sum of 4 quarters · filed 2015-03-11
2013-03-31$691.95K
10-Q · filed 2014-05-12
$570.88K
10-Q · filed 2013-05-10
$1.09M
derived: sum of 2 quarters · filed 2015-03-11
$1.61M
derived: sum of 3 quarters · filed 2015-03-11
$2.22M
derived: sum of 4 quarters · filed 2015-03-11
2012-12-31$402.83K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11
$914.71K
derived: sum of 2 quarters · filed 2015-03-11
$1.53M
derived: sum of 3 quarters · filed 2015-03-11
$1.84M
10-K · filed 2015-03-11
$1.28M
10-K · filed 2013-03-18
2012-09-30$511.88K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12
$1.13M
derived: sum of 2 quarters · filed 2013-11-12
$1.44M
10-Q · filed 2013-11-12
$986.77K
10-Q · filed 2012-11-09
$2.42M
derived: sum of 4 quarters · filed 2014-03-17
2012-06-30$613.20K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09
$929.26K
10-Q · filed 2013-08-09
$614.50K
10-Q · filed 2012-08-09
$1.90M
derived: sum of 3 quarters · filed 2014-03-17
$2.17M
derived: sum of 4 quarters · filed 2014-03-17
2012-03-31$316.06K
10-Q · filed 2013-05-10
$1.29M
derived: sum of 2 quarters · filed 2014-03-17
$1.56M
derived: sum of 3 quarters · filed 2014-03-17
$1.83M
derived: sum of 4 quarters · filed 2014-03-17
2011-12-31$974.02K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17
$1.24M
derived: sum of 2 quarters · filed 2014-03-17
$1.51M
derived: sum of 3 quarters · filed 2014-03-17
$1.80M
10-K · filed 2014-03-17
$1.22M
10-K · filed 2012-03-14
2011-09-30$268.31K
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09
$538.86K
derived: sum of 2 quarters · filed 2012-11-09
$828.39K
10-Q · filed 2012-11-09
$1.04M
derived: sum of 4 quarters · filed 2013-03-18
2011-06-30$270.54K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$560.08K
10-Q · filed 2012-08-09
$769.36K
derived: sum of 3 quarters · filed 2013-03-18
$914.66K
derived: sum of 4 quarters · filed 2013-03-18
2011-03-31$289.54K
10-Q · filed 2012-05-10
$498.81K
derived: sum of 2 quarters · filed 2013-03-18
$644.12K
derived: sum of 3 quarters · filed 2013-03-18
2010-12-31$209.27K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18
$354.58K
derived: sum of 2 quarters · filed 2013-03-18
$638.71K
10-K · filed 2013-03-18
2010-09-30$145.31K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-08
$429.44K
10-Q · filed 2011-11-08
2010-06-30$284.13K
10-Q · filed 2011-08-09
2009-12-31$260.84K
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Alector, Inc. (ALEC)United States$0.213B-1.90
Invivyd, Inc. (IVVD)United States$0.270B-2.42
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51